Salma Health, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Salma Health, Inc. - overview

Location

San Mateo, CA, US

Primary Industry

Healthcare Specialists

About

Salma Health, Inc. is a US-based company focused on delivering personalized brain healthcare solutions, including advanced therapies for a variety of mental health disorders, ensuring patients receive tailored and effective treatments. Salma Health specializes in personalized mental health treatment, primarily offering innovative therapies to address conditions like depression and PTSD. The company was established in San Mateo, California, and has expanded its services across the state, with locations in Orange County, San Diego, and the Bay Area.


Salma Health raised USD 80 mn in Series A funding on February 26, 2026, led by Mubadala Capital and ARCH Venture Partners, among others. The total amount raised by the company to date is USD 80 mn. Salma Health specializes in personalized brain healthcare, offering evidence-based treatments for mental health challenges such as depression, anxiety, PTSD, and obsessive-compulsive disorder. Key services include Transcranial Magnetic Stimulation (TMS), Spravato® (esketamine) therapy, and the SAINT® program.


The company also provides virtual intensive outpatient programs and medication management, with a comprehensive evaluation process that leads to tailored care plans based on individual patient needs. Salma Health operates clinics across California, with plans for expansion into the Los Angeles area. Salma Health generates revenue through direct-to-consumer mental health treatment services. Clients initiate their care journey by scheduling consultations, after which their insurance coverage is validated to facilitate access to various treatment options.


With proprietary therapies such as TMS and Spravato®, pricing is designed to accommodate both insured and out-of-pocket clients. The company collaborates with major insurance providers, enabling many patients to receive care through insurance reimbursement. In February 2026, Salma Health, Inc. successfully raised USD 80 mn in Series A funding to support its clinical expansion, technology development, and research operations.


The company plans to launch new products aimed at enhancing mental health treatments and expand its services into the Los Angeles market. Recent funding will be utilized to further these initiatives, strengthening Salma Health's position in the mental health sector.


Current Investors

ARCH Venture Partners, Mubadala Capital, Lingotto Investment Management LLP

Primary Industry

Healthcare Specialists

Sub Industries

Mental Health Services

Website

www.salmahealth.com

Company Stage

Series A

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.